Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize March 25-31 as National Physicians Week. This week and throughout the year, we celebrate the dedication of physicians who selflessly devote their time and energy to ensure the health and well-being of those in need of care.
Physicians are vital to this country’s healthcare system, offering essential services to millions of individuals facing chronic illnesses and complex conditions. The physicians AIS Healthcare partners with are integral to delivering the highest quality care to vulnerable patient populations across the country. Collaboration between physicians and AIS Healthcare ensures that patients receive their specialized medications in a timely and efficient manner. AIS is proud to work with doctors to advance the quality of patient care and improve lives in the process.
“National Physicians Week is an opportunity to recognize the never-ending dedication and hard work of doctors across the country” said Simon Castellanos, CEO of AIS Healthcare. “At AIS Healthcare, we work with doctors every day to enhance the quality of care for the patients we serve. Today, we celebrate their countless contributions to patients and communities.”
AIS Healthcare uses innovative healthcare solutions to make the treatment process intuitive and helpful for all. AIS services act as an extension of physicians’ practices, enhancing the care experience for both patients and providers.
During National Physicians Week, AIS Healthcare encourages everyone to show their appreciation for the physicians in their lives. Whether through a kind gesture or a heartfelt thank you, this week is an opportunity to show our appreciation for the selflessness and dedication of the nation’s doctors. To learn more about AIS Healthcare and our work with doctors in supporting patients nationwide, visit here.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
CONTACT:
Jud Hall
877.443.4006
Dallas, Texas – AIC, a division of AIS Healthcare, now offers GLASSIA and ARALAST NP, manufactured by Takeda, for the treatment of adult patients with clinically evident emphysema due to severe hereditary deficiency of Alpha1-PI (alpha1-antitrypsin deficiency).
The nationally accredited home infusion teams at AIC collaborate closely with physicians to provide specialized infusion services to patients in their home or at an infusion suite setting. The addition of these therapy options expands AIC’s ability to better serve patients with alpha1-antitrypsin deficiency.
“We’re excited and proud to be able to add Takeda’s Alpha₁ therapies to our growing portfolio of infusion therapies,” said Jud Hall, President at AIC. “The addition of GLASSIA and ARALAST NP can help us provide patients with more options to meet individual treatment needs.”
Approved by the U.S. Food and Drug Administration (FDA) in 2010 and 2002, respectively, GLASSIA and ARALAST NP are Alpha1-Proteinase Inhibitors (Human) (Alpha1-PI) indicated for chronic augmentation therapy in adults with clinically evident emphysema due to severe hereditary deficiency of Alpha1-PI. ARALAST NP increases antigenic and functional (anti-neutrophil elastase capacity, ANEC) serum levels and antigenic lung epithelial lining fluid levels of Alpha1-PI.
The effect of augmentation therapy with GLASSIA, ARALAST NP, or any Alpha1-PI product on pulmonary exacerbations and on the progression of emphysema in Alpha1-PI deficiency has not been conclusively demonstrated in randomized, controlled clinical trials. Clinical data demonstrating the long-term effects of chronic augmentation and maintenance therapy of individuals with GLASSIA or ARALAST NP are not available. GLASSIA and ARALAST NP are not indicated as therapies for lung disease in patients in whom severe Alpha1-PI deficiency has not been established.
Both GLASSIA and ARALAST NP are now available at all AIC locations (Valdosta, Georgia; Birmingham, Alabama; Panama City, Florida; Dallas, Texas).
Like all AIC patients, those with alpha1-antitrypsin deficiency will receive a high level of care from AIC, including 24/7 access to clinical and support staff.
Every patient is assigned a dedicated team of professionals, including clinical pharmacists, home infusion nurses, RN clinical review specialists and patient onboarding specialists to provide support throughout the treatment process.
For providers, AIC is a full-service care delivery partner. We also work directly with patients, insurance companies, and provider offices to secure all needed insurance authorizations and approvals.
AIC is dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further setting it apart from other infusion services providers.
Physicians interested in AIC care services should contact their AIC representatives to get started or visit us at www.aiscaregroup.com/our-divisions/infusion-care/
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com.
Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit www.takeda.com.
Contact:
Simon Castellanos
877.443.4006Well-Being First
Dallas, Texas – AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize the week of March 10th as Patient Safety Awareness Week. Established in 2002, this week is an opportunity to highlight the importance of equipping healthcare professionals and the general public with the knowledge needed to secure the most optimal health services and outcomes.
Some of the most common mistakes that can lead to patient harm are the result of system or process failures. Making the proper investments in patient safety can positively impact health outcomes, reduce overall healthcare costs, and earn the trust of patients in the healthcare system. At AIS Healthcare, patient safety is the top priority, which is why AIS meets and exceeds state and industry standards to produce patient-specific prescriptions of the highest quality and sterility. AIS uses a proven, proprietary process that combines aseptic processing with terminal sterilization on patient-specific prescriptions to achieve higher sterility assurance and extended Beyond-Use Dates (BUD).
“AIS Healthcare is proud to recognize Patient Safety Awareness Week and remains committed to elevating patient safety in every facet of our business,” said Simon Castellanos, CEO of AIS Healthcare. “Every day, the patients we serve entrust us with their care. It is our responsibility to take the time and make the investments to ensure their safety is put first in everything we do.”
AIS Healthcare ships more than 145,000 patient-specific prescriptions annually to all 50 states and is committed to advancing the quality of life and safety for all patients. AIS streamlines the care delivery process and goes above and beyond to maintain the highest possible quality of medications.
AIS Healthcare carries dual accreditation from URAC and the Accreditation Commission for Health Care (ACHC), setting it apart as an industry leader in targeted drug delivery and infusion care. AIS Healthcare is committed to advancing quality and improving patient lives.
To learn more about AIS Healthcare’s services, visit here.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas -AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize March as Brain Injury Awareness Month. This month reminds us of the importance of improving the quality of life for people impacted by brain injury through elevating awareness and advocacy and delivering the highest quality healthcare.
Brain injuries are widespread, and the impact on an individual and their family is not widely understood or appreciated. According to the CDC, more than 5.3 million individuals in the United States live with a brain injury or brain injury-related disability, and an average of 1.5 million traumatic brain injuries (TBI) occur each year. Post-brain injury treatment is a lifelong journey, often requiring specialized healthcare services and chronic pain treatment. AIS Healthcare is dedicated to ensuring patients living with a TBI and managing complex conditions can lead full, meaningful lives in their homes and local communities.
“The strength and resilience of the brain injury community are tremendous, and I welcome the strides made by the physical and behavioral health industries to elevate research, advocacy, and awareness on behalf of this important group,” said Simon Castellanos, CEO of AIS Healthcare. “This month and every month, we seek to empower individuals living with a brain injury by delivering the best possible in-home healthcare services and pain management solutions. We will always be an ally to this inspiring part of our larger patient community.”
Brain injuries often happen through absolutely no fault of the injured person. AIS Healthcare wants to remind everyone to take proper precautions to reduce the chance of brain injury by wearing seatbelts, helmets, and never driving impaired. To find more ways to support the brain injury community, contact your local brain injury association by visiting here.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize the first week of February as National Patient Recognition Week. Since its founding in 2008, AIS Healthcare has provided comprehensive care services to patients across the country, going beyond state and industry standards to produce patient-specific prescriptions of the highest quality. Patients deserve the highest quality care possible and through exceptional TDD and infusion care services, AIS Healthcare is committed to advancing and improving the quality of life for all patients.
National Patient Recognition Week was established by the American Medical Association in 1995 and is an opportunity for healthcare professionals to reaffirm their commitment to a patient-first healthcare approach. Throughout the year, AIS Healthcare ships more than 145,000 prescriptions nationwide for patients managing chronic pain and other complex conditions. In addition to the company’s pharmacy services, AIS’ skilled nursing staff provides patient-specific care across the country from in-home immunoglobulin therapy to TDD pump refill and maintenance.
“When patients are served by AIS Healthcare, they can always expect us to put their safety, comfort, and well-being first,” said AIS Healthcare CEO Simon Castellanos. “We are grateful for the trust our patients put in us each and every day and are committed to helping all patients achieve the best possible health outcomes and quality of life.”
AIS Healthcare’s two state-of-the-art 503A compounding pharmacies exceed industry safety standards, and patient-specific prescriptions achieve unparalleled sterility. Advanced Infusion Care (AIC), a division of AIS Healthcare, operates a total of five pharmacies, dispensing essential medications and personalized care to patients across the United States with complex medical conditions like immune deficiency diseases.
AIS Healthcare carries dual accreditation from URAC and the Accreditation Commission for Health Care (ACHC), setting it apart as an industry leader in targeted drug delivery and infusion care. During this National Patient Recognition Week and beyond, AIS Healthcare will remain committed to a patient-first, empathetic approach to healthcare and changing patient lives for the better.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – AIS Healthcare, the leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize January 12th as National Pharmacist Day. On this day and throughout the year, AIS Healthcare recognizes and honors the critical role pharmacists play in the continuum of patient care.
At AIS Healthcare, pharmacists go beyond what’s expected to deliver medications of the highest quality and sterility, earning recognition from the top independent pharmacy accreditors, URAC and the Accreditation Commission for Health Care (ACHC). Through a double-blind order verification process, AIS Healthcare’s TDD pharmacy technicians and pharmacists work together to ensure that medications are compounded appropriately. They also educate patients about their medications and collaborate with physicians to enhance the quality-of-care patients receive.
In recent years, the role of pharmacists has expanded, becoming an integral part of the health care system and playing an important role in patient care and recovery. Their service on behalf of patients across the country deserves to be celebrated.
“I am proud of the work of our pharmacy team and pharmacists across the country, who consistently go above and beyond to deliver safe and effective healthcare solutions to patients and their families. Their dedication and diligence are the lifeblood of our work and a key pillar of our healthcare system”, said Simon Castellanos, AIS Healthcare CEO. “Our organization is committed to continue making all the investments necessary to deliver medications of the highest possible quality for the patients and providers we serve.”
AIS Healthcare TDD operates two state-of-the-art 503A compounding pharmacies in Dallas, Texas, and Ridgeland, Mississippi, where pharmacists use a proven, proprietary process that combines aseptic processing with terminal sterilization on patient-specific formulary prescriptions to achieve unprecedented sterility assurance and extended Beyond-Use Dates (BUD). Our workspaces exceed industry standards and utilize several methods that guarantee the safety of the systems we use and the medications we produce for our patients.
Advanced Infusion Care (AIC), a division of AIS Healthcare, operates a total of five pharmacies, dispensing essential medications and personalized care to patients across the United States with complex medical conditions like immune deficiency diseases.
AIC supports patients by making medications more accessible to those in need of infusion care solutions, delivering 24/7 access to a dedicated team of clinical and support staff. Clinical pharmacists work directly with patients to address their care and provide professional assistance in the selection of Ig products that meet their unique needs.
AIS Healthcare is proud to celebrate National Pharmacist Day and acknowledges the vital
contributions of pharmacists in helping patients live healthy and full lives. For more information about AIS pharmacies, visit here.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Dallas, Texas – As 2023 draws to a close, AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to announce that it reached the milestone of dispensing one million prescriptions to patients living with chronic pain and other complex health conditions earlier this year. Since its inception more than 10 years ago, AIS Healthcare has been putting quality and safety first in the preparation and delivery of patient-specific prescriptions across the country.
At AIS Healthcare’s two 503A specialty compounding pharmacies, best-in-class licensed pharmacists go beyond state and industry standards to produce medications of the highest quality and sterility. Both facilities invest significant resources in people and processes to be able to produce prescriptions that exceed standards and expectations, using a proven, proprietary process that combines aseptic processing with terminal sterilization—a pharmaceutical industry standard—for patient-specific formulary prescriptions to achieve unprecedented sterility assurance and extended Beyond-Use Date (BUD). This gives providers confidence in the medications they prescribe and helps to reduce medication waste.
“AIS is proud to administer life-changing medications across the United States that improve patients’ quality of life. The achievement of dispensing one million prescriptions is a significant milestone. We remain committed to prioritizing patient safety in every aspect—from person to process to protocol. Our dedication to maintaining the highest standards of quality in healthcare is unwavering. We look forward to continuing the work of advancing quality and enabling patients to live better lives,” said Simon Castellanos, AIS Healthcare CEO.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to announce that it is has been awarded accreditations for Specialty Pharmacy, Infusion Pharmacy, and Infusion Nursing by the Accreditation Commission for Health Care (ACHC), an internationally recognized accrediting body, further setting it apart from other infusion services providers. This accomplishment underscores the company’s commitment to going beyond what’s expected to advance quality care and improve the lives of patients.
Formed in 1986, the Accreditation Commission for Health Care grants accreditation for providers in the home care and home infusion therapy industries. The Commission plays a critical role in ensuring providers deliver quality and effective services to patients. Accreditation also helps providers like AIS Healthcare to demonstrate their ability to meet official regulatory requirements and standards, resulting in a higher level of performance and a greater focus on patient care.
“This accomplishment is a testament to our employees who commit themselves to providing the highest quality care to our patients. We will continue to take the steps necessary to ensure every one of our employees, every process, and every protocol puts patient safety first. Thank you to ACHC for this important recognition and to the entire team at AIS Healthcare for their dedication to the patients we serve,” said Simon Castellanos, AIS Healthcare CEO.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – AIS Healthcare, the leading provider of targeted drug delivery and infusion care solutions, is proud to recognize December 5th as International Volunteer Day. Established in 1983, the special day is meant to acknowledge the spirit of volunteerism and giving back to one’s community at the local, national, and international level. Since its founding in 2008, AIS Healthcare has championed a workplace culture that values the unique and impactful contributions of its employees in the communities where they live and work.
AIS Healthcare is committed to supporting the many communities in which we do business and serve patients. To further this commitment, AIS Healthcare recently introduced a Volunteer Time Off paid leave benefit to allow team members to serve their communities and the charities of their choosing. This past year, our employees volunteered at the North Texas Food Bank, Ronald McDonald House Charities, Keep Jackson Beautiful, and Habitat for Humanity to name a few.
AIS Healthcare also instituted an Inclusion Council in 2021, a cross-departmental group of leaders dedicated to promoting diversity and inclusion within the company. Since its inception, the Inclusion Council has created a calendar with a theme that highlights the diversity of our organization. This year’s theme focuses on volunteerism, highlighting the company’s commitment to making a difference in our home communities.
“AIS prides itself on going beyond what’s expected to deliver the highest quality services to our patients. This includes an obligation to serve our communities and fellow neighbors. I am immensely proud of the time and energy our team devotes to the communities they call home,” said Simon Castellanos, AIS Healthcare CEO.
AIS Healthcare encourages employees with a passion for a cause or ideas on community service to share them with the Inclusion Council. The company celebrates the great service of its employees and encourages them to continue having a positive impact on the communities in which they live and work.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize National Pharmacy Week, an annual observance that takes place from October 15th – October 21st and first began in 1925. The week spotlights the critical role of pharmacists and pharmacy technicians across the healthcare industry and their contributions in advancing high-quality patient care.
“The dedication and commitment of our pharmacy teams are at the core of our mission to improve patient lives by ensuring that every person, every process, and every protocol puts patient safety first. During National Pharmacy Week, we recognize and celebrate our team’s unwavering commitment to patient care and their vital role in ensuring all our patients receive safe and effective medications,” said Simon Castellanos, CEO of AIS Healthcare.
AIS Healthcare operates two “state-of-the-art” 503A compounding pharmacies in Dallas, Texas, and Ridgeland, Mississippi where pharmacists use a proven, proprietary process that combines aseptic processing with terminal sterilization—a pharmaceutical industry standard—on patient-specific formulary prescriptions to achieve unprecedented sterility assurance and extended Beyond-Use Dates (BUD).
Pharmacists play an important role in improving patient outcomes by ensuring that medications are compounded and used appropriately, educating patients about their medications, and collaborating with physicians to enhance the quality of care for our patients. Our pharmacy teams are critical in achieving dual accreditation by URAC and the Accreditation Commission for Health Care (ACHC), further setting AIS Healthcare apart from other compounding pharmacies and infusion services providers.
AIS Healthcare is proud to celebrate National Pharmacy Week and acknowledges the vital contributions of pharmacists and pharmacy technicians in delivering safe, effective, and innovative healthcare solutions to patients across the nation. For more information about National Pharmacy Week and the American Society of Health-System Pharmacists, please visit here.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com